{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-11249", "FDA", "Request that the FDA declare that the drug products Furosemide Capsules, 20 mg, 40 mg, and 80 mg, are suitable for consideration in an Abbreviated New Drug Application (ANDA)", "Nonrulemaking", "2026-10-14T21:37:06Z", "0b000064b95c0cf5", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-11249"], "units": {}, "query_ms": 0.1923211384564638, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}